â€œRealising the full benefit from new technologies will be a high priority for all life sciences companies as commercialisation approaches are revised amid changing customer demands and a growing need for efficiency,â€ said Murray Aitken, executive director, IMS Institute for Healthcare Informatics. â€œApplications that are healthcare-specific, cloud-based, integrated, secure and analytically powerful will yield substantial advantages to these organisations, and ultimately to patients and the health system overall.â€
"With a raft of pharmerging countries rapidly gaining market share, we're seeing a new world order take hold within the pharmaceutical industry," said Murray Aitken, senior vice president, Healthcare Insight, IMS.
" In 2007, the market will still be absorbing changes that have defined a new economic reality, one in which growth is shifting from mature markets to emerging ones; new product adoption is not keeping pace with the loss of patent protection by established products; specialty and niche products are playing a larger role; and regulators, payers and consumers are more carefully weighing the risk/benefit factors of pharmaceuticals.", says Murray Aitken, Senior VP, Corporate Strategy at IMS.
â€œIncreasingly, patients are turning to social media as an essential forum for obtaining and sharing information related to their health,â€ Murray Aitken, executive director of the IMS Institute for Healthcare Informatics, writes in the report.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.